Skip to content

Dr. Jonathan Silcock,
Associate Professor

Information about Dr. Jonathan Silcock at the University of Bradford.

School of Pharmacy & Medical Sciences
(Faculty of Life Sciences)
+44 1274 236624
Photo of Dr. Jonathan Silcock


An academic pharmacist in theSchool of Pharmacy and Medical Sciences (SoPMS) at University of Bradford with specialistexpertise in pharmacy and medicines management. Responsible for work-based learning and employer engagement. Teaching in pharmacy practice, evidence-based healthcare, ethics and research design. Holds researchleadership roles in the ISCOMAT NIHR PGfAR and the deprescribing researchprogramme in Y&H Patient Safety Translational Research Centre. Member of Health Education England's operations group for pre-registration pharmacy training. External examiner for post-graduate programmes at Medway School of Pharmacy and MPharm programme at King's College London.


Programme co-lead, ISCOMAT (Improving the Safety and Continuity of Medicines Management at Care Transitions) Programme (NIHR funded). Workstream lead (InterventionDevelopment & Implementation), Deciding to Deprescribe programme (Yorkshire& Humber Patient Safety Translational Research Centre). Research supervision: medicines optimisation; medicines and frailty.

Professional activities

Information about education, employment and areas of particular interest for Dr. Jonathan Silcock is as follows:


  • University of Aberdeen - Research Assistant in the year 1993 (specified as 01/01/1993)
  • University of Bradford - Senior Lecturer in Pharmacy Practice in the year 2009 (specified as 01/10/2009)
  • University of Leeds - Lecturer in Pharmacy in the year 2004 (specified as 01/09/2004)
  • Leeds Teaching Hospitals NHS Trust - Pharmacy Research Manager in the year 2000 (specified as 01/04/2000)
  • Boots UK Ltd - Teacher Practitioner in the year 1996 (specified as 01/06/1996)


  • University of Bradford - BPharm (Hons)
  • University of York - MSc
  • University of Leeds - Postgraduate Certificate
  • University of Leeds - PhD


There are 41 publications involving or that are attributed to Dr. Jonathan Silcock.

Peer Reviewed Journal

Dr. Jonathan Silcock has 41 publication(s) listed under peer reviewed journal.
Title Year Publication name Journal Volume Pages Authors Editors ISSN Publisher DOI Location
Explanations for variations in clopidogrel prescribing in England. 2011 Petty, Duncan R.; Silcock, Jonathan
How effective are pharmacists who work with medical practitioners? A study of interventions intended to influence prescribing 2002 International Journal of Pharmacy Practice 10 185 - 190 Teal S.;Ricketts L.;Belton A.;Allsopp G.;Silcock J.;Wright D. 0961-7671 10.1111/j.2042-7174.2002.tb00607.x
"User-testing" as a method for testing the fitness-for-purpose of written medicine information 2011 Patient Education and Counseling 83 404 - 410 Raynor D.;Knapp P.;Silcock J.;Parkinson B.;Feeney K. 0738-3991 10.1016/j.pec.2011.03.016
Can user testing of a clinical trial patient information sheet make it fit-for-purpose? - A randomized controlled trial 2011 BMC Medicine 9 Knapp P.;Raynor D.;Silcock J.;Parkinson B. 1741-7015 10.1186/1741-7015-9-89
The impact of the pharmacist on an elective general surgery pre-admission clinic 2001 Pharmacy World and Science 23 65 - 69 Hick H.;Deady P.;Wright D.;Silcock J. 0928-1231 10.1023/A:1011231622947
Prescribing of lipid lowering drugs to South Asian patients: Ecological study 2002 British Medical Journal 325 25 - 26 Patel M.;Wright D.;Gill P.;Jerwood D.;Silcock J.;Chrystyn H. 0959-8146
The cost-effectiveness of intensive pharmaceutical intervention in assisting people to stop smoking 1999 International Journal of Pharmacy Practice 7 107 - 112 Sinclair H.;Silcock J.;Bond C.;Lennox A.;Winfield A. 0961-7671 10.1111/j.2042-7174.1999.tb00957.x
How effective are primary care pharmacists at running dyspepsia clinics for patients prescribed PPIs? 2018 Petty, Duncan R.; Allan, J.; Dawson, R.; Silcock, Jonathan
Is Medication Review by Primary-Care Pharmacists for Older People Cost Effective? 2009 PharmacoEconomics Arnold G. Zermansky;Jonathan Silcock; 10.2165/00019053-200927010-00003
Performance-based readability testing of participant information for a Phase 3 IVF trial 2009 Trials Peter Knapp;DK Raynor;Jonathan Silcock;Brian Parkinson; 10.1186/1745-6215-10-79
Explanations for variations in clopidogrel prescribing in England 2008 Public Health Petty, D.R.;Silcock, J.; 10.1093/pubmed/fdn048
Does expert writing and information design improve understanding of a clinical trial participant information sheet? An RCT 2010 International Journal of Pharmacy Practice Knapp, P.;Raynor, D.K.;Silcock, J.;Parkinson, B.; 10.1111/j.2042-7174.2010.00015.x
Performance-based readability testing of participant materials for a phase I trial: TGN1412 2009 Journal of Medical Ethics Knapp, P.;Raynor, D.K.;Silcock, J.;Parkinson, B.; 10.1136/jme.2008.026708
Exploring patient adherence to cardiovascular medicines 2007 British Journal Of Cardiac Nursing Jonathan Silcock;Claire Standage; 10.12968/bjca.2007.2.5.23462
The organisation and development of primary care pharmacy in the United Kingdom 2004 Health Policy Jonathan Silcock;D.K.Theo Raynor;Duncan Petty; 10.1016/s0168-8510(03)00121-0
Continuing professional development for employee pharmacists: A survey to compare practice in the hospital and community sectors 2004 Pharmaceutical Journal Swainson, D.;Silcock, J.;
How do patients use medicine information leaflets in the UK? 2007 International Journal of Pharmacy Practice Raynor, D.K.;Silcock, J.;Knapp, P.;Edmondson, H.; 10.1211/ijpp.15.3.0008
Do community pharmacists have the attitudes and knowledge to support evidence based self-management of low back pain? 2007 BMC Musculoskeletal Disorders Silcock, J.;Moffett, J.;Edmondson, H.;Waddell, G.;Burton, A.K.; 10.1186/1471-2474-8-10
Consumer medication information in the United States, Europe, and Australia: A comparative evaluation 2007 Journal Of The American Pharmacists Association Theo Raynor, D.K.;Svarstad, B.;Knapp, P.;Aslani, P.;Brooke Rogers, M.;Koo, M.;Krass, I.;Silcock, J.; 10.1331/JAPhA.2007.06141
The cost-effectiveness of pharmacist-led treatment of cardiac risk in patients with type 2 diabetes 2007 Pharmacy World and Science Lowey, A.;Moore, S.;Norris, C.;Wright, D.;Silcock, J.;Hammond, P.; 10.1007/s11096-007-9101-7
Trends in psychotropic drug use in older patients in general hospitals 2003 Pharmaceutical Journal Holmes, J.;Millard, J.;Greer, D.;Silcock, J.;
An audit of hospital discharge and outpatient information from a primary care perspective 2001 Journal of Social and Administrative Pharmacy Coleman, A.;Ricketts, L.;Teal, S.;Mitchell, E.;Silcock, J.;Wright, D.J.;
The 1990 GP contract — meeting needs? 1996 Health Policy Jonathan Silcock;Julie Ratcliffe; 10.1016/0168-8510(95)00810-1
The Cost of Medicines in the United Kingdom 1997 PharmacoEconomics Jonathan Silcock;Mandy Ryan;Christine M. Bond;Ross J. Taylor; 10.2165/00019053-199711010-00007
The primary health care team and smoking cessation: An effective contribution from community pharmacy? 1997 Pharmaceutical Journal Bond, C.M.;Sinclair, H.K.;Scott Lennox, A.;Silcock, J.;Winfield, A.J.;
An economic evaluation of thrombolysis in a remote rural community 1997 British Medical Journal Vale, L.;Silcock, J.;Rawles, J.;
A comparison of smokers' and ex-smokers' health-related quality of life 1997 Public Health Medicine Tillmann, M.;Silcock, J.;
Changes in Scottish GPs' attitudes and knowledge in respect of prescribing costs between 1986 and 1995 1996 European Journal of General Practice Silcock, J.;Ryan, M.;Bond, C.M.;Taylor, R.J.; 10.3109/13814789609161559
Economic evaluation of pharmacy services - Fact or fiction? 1999 Pharmacy World and Science George, B.;Silcock, J.; 10.1023/A:1008748920744
Training pharmacists and pharmacy assistants in the stage-of-change model of smoking cessation: A randomised controlled trial in Scotland 1998 Tobacco Control Sinclair, H.K.;Bond, C.M.;Lennox, A.S.;Silcock, J.;Winfield, A.J.;Donnan, P.T.; 10.1136/tc.7.3.253
An evaluation of a training workshop for pharmacists based on the Stages of Change model of smoking cessation 1997 Health Education Journal Sinclair, H.;Bond, C.;Lennox, A.S.;Silcock, J.;Winfield, A.; 10.1177/001789699705600309
The 1990 GP Contract: Modelling variation in minor surgery provision 1995 Mathematical Medicine and Biology Jonathan Silcock;Julie Ratcliffe; 10.1093/imammb/12.3-4.203
Medication-related risk factors and its association with repeated hospital admissions in frail elderly: A case control study 2019 Cheong, V-Lin; Sowter, Julie; Scally, Andy J.; Hamilton, N.; Ali, A.; Silcock, Jonathan
Adherence to coronary artery disease secondary prevention medicines: exploring modifiable barriers 2019 Open Heart 6 Khatib, R; Marshall, K; Silcock, J; Forrest, C; Hall, A BMJ doi:10.1136/ openhrt-2018-000997
Experience-based co-design - Adapting the method for a researcher-initiated study in a multi-site setting 2020 Health Expectations 23 562 - 570 Raynor D.;Ismail H.;Blenkinsopp A.;Fylan B.;Armitage G.;Silcock J. 1369-6513 10.1111/hex.13028
Professional identity formation of pharmacy students during an early pre-registration training placement 2020 American Journal of Pharmaceutical Education 84 Quinn G, Lucas B and Silcock J American Association of Colleges of Pharmacy
Successful care transitions for older people: a systematic review and meta-analysis of the effects of interventions that support medication continuity. 2020 Age and Ageing Tomlinson J;Cheong VL;Fylan B;Silcock J;Smith H;Karban K;Blenkinsopp A; 1468-2834 10.1093/ageing/afaa002
Optimised patient information materials and recruitment to a study of behavioural activation in older adults: an embedded study within a trial 2020 F1000 Research 9 417 Knapp P.;Gilbody S.;Holt J.;Keding A.;Mitchell N.;Raynor D.K.;Silcock J.;Torgerson D. 2046-1402 10.12688/f1000research.24051.1
Post-discharge medicines management: the experiences, perceptions and roles of older people and their family carers. 2020 Health Expectations Tomlinson J;Silcock J;Smith H;Karban K;Fylan B; 1369-7625 10.1111/hex.13145
Using experience-based co-design with patients, carers and healthcare professionals to develop theory-based interventions for safer medicines use 2021 Research In Social & Administrative Pharmacy : Rsap Fylan B, Tomlinson J, Raynor DK, Silcock J
A non-randomised feasibility study of an intervention to optimise medicines at transitions of care for patients with heart failure. 2021 Pilot And Feasibility Studies 7 Fylan B; Ismail H; Hartley S; Gale CP; Farrin AJ; Gardner P; Silcock J; Alldred DP; 2055-5784 10.1186/s40814-021-00819-x